]>
IRCT2016092429936N1 IRCT 2016-12-23 Vice Chancellor for Research and Technology Mashhad University of Medical Sciences The effects of traditional medicine product in genital wart Comparison the effect of herbal product " Myrtus communis " with placebo on the treatment of genital warts in women 2016-11-21 anticipated 60 Complete https://irct.ir/trial/23937 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment. N/A Condition 1: Genital wart. Condition 2: Cervix dysplasia. Condition 3: vaginal dysplasia. Condition 4: papilloma of cervix. Intervention 1: Patients are treated with 60 Myrtus vaginal suppositories one every night except during menstruation period in the intervention group . Disease status will be reviewed at the beginning and the end of the study. Intervention 2: Patients are treated with 60 placebo vaginal suppositories one every night except during menstruation period in the control group. Disease status will be reviewed at the beginning and the end of the study.
public Zahra Nikakhtar
Faculty of Iranian Traditional Medicine and Complementary, Opposite the Mehran sports hall, East Razi Ave.
Mashhad Iran (Islamic Republic of) +98 51 3855 2189 nikakhtarz1@mums.ac.ir Faculty of Iranian Traditional Medicine and Complementary of Mashhad University of Medical Sciences scientific Zohre Feyzabadi
Faculty of Iranian Traditional Medicine and Complementary, Opposite the Mehran sports hall, East Razi Ave.
Mashhad Iran (Islamic Republic of) +98 51 3855 2189 Feyzabadiz@mums.ac.ir Faculty of Iranian Traditional Medicine and Complementary of Mashhad University of Medical Sciences Iran (Islamic Republic of) Iran (Islamic Republic of) Inclusion criteria: Female patient with vaginal or cervical wart; age between 18 to 50 years Exclusion criteria: patient with Candida, trichomona and other infections vaginitis or cervicitis; patients with recognized immunodeficiency or autoimmune disease; HIV positive patients; Long-term use of corticosteroids or immunosuppressive; smoking; pregnancy; those who had CIN2 and CIN3 in cervix biopsy; Lack of satisfaction in every stage of the study 18 years 50 years Female A63.0 N87.0 N89,0 D26,0 Anogenital (venereal) warts Mild cervical dysplasia Mild vaginal dysplasia Other benign neoplasms of uterus Treatment - Drugs Placebo Patients are treated with 60 Myrtus vaginal suppositories one every night except during menstruation period in the intervention group . Disease status will be reviewed at the beginning and the end of the study. Patients are treated with 60 placebo vaginal suppositories one every night except during menstruation period in the control group. Disease status will be reviewed at the beginning and the end of the study. HPV virus. Timepoint: Baseline, the end of the study. Method of measurement: HPV-PCR test. Lesion size. Timepoint: Baseline,the end of the study. Method of measurement: Colposcopy. Clinical symptom. Timepoint: Baseline,end of the first and the second and the third month of the study. Method of measurement: According to the patient's symptoms. Drug Side Effects. Timepoint: During the study. Method of measurement: According to the patient's symptoms. Vice Chancellor for Research and Technology Mashhad University of Medical Sciences Approved 2016-08-27 Mashhad University of Medical Sciences Vice Chancellor for Research and Technology Mashhad University of Medical Sciences, Building Qureshi, Daneshgah Ave. Mashhad Iran (Islamic Republic of)